Skip to main navigation Skip to search Skip to main content

Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report

Research output: Contribution to journalArticlepeer-review

Abstract

We describe a 70-year-old Haitian man who had been taking warfarin for 5 years for atrial fibrillation and pulmonary hypertension. This patient had his international normalized ratio (INR) checked in the pharmacist-run anticoagulation clinic and was followed monthly. Prior to the interaction, his INR was therapeutic for 5 months while taking warfarin 10.5 mg/d. The patient presented with an INR > 8.0. Patient held 4 days of warfarin and restarted on warfarin 8.5 mg/d. Two weeks later, his INR was 2.5. After continuing dose, patient presented 2 weeks later and INR was 4.8. Upon further questioning, the patient stated he recently began ingesting mauby. Mauby is a bitter dark liquid extracted from the bark of the mauby tree that is commonly used in the Caribbean population as a folk remedy with many health benefits. This case report illustrates that mauby may have a probable drug-herb interaction (Naranjo Algorithm Score of 6) when given with warfarin. There is a lack of published literature and unclear information on the Internet describing the interaction of mauby and warfarin. Health professionals should be cautious regarding interactions between warfarin and mauby until the interaction is fully elucidated.

Original languageEnglish
Pages (from-to)567-570
Number of pages4
JournalJournal of Pharmacy Practice
Volume30
Issue number5
DOIs
StatePublished - Oct 1 2017

Bibliographical note

Publisher Copyright:
© The Author(s) 2016.

ASJC Scopus Subject Areas

  • Pharmacology (medical)

Keywords

  • anticoagulation
  • Colubrina arborescens
  • INR
  • mauby
  • warfarin

Disciplines

  • Medical Pharmacology

Fingerprint

Dive into the research topics of 'Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report'. Together they form a unique fingerprint.

Cite this